Search clinical trials for: Diabetes Mellitus - Type 2

Total 105098 results

Maastricht University Medical Center

Completed

Vinegar Co-ingestion in Type 2 Diabetes

Type 2 Diabetes Mellitus

Netherlands
Karolinska Institutet
The Swedish Research Council; Actelion; Swedish Heart Lung Foundation

Completed

Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes (BANDY)

Type 2 Diabetes Mellitus

Sweden
JW Pharmaceutical

Completed

Therapeutic Exploratory Study of CWP-0403

Type 2 Diabetes Mellitus

Korea, Republic of
AstraZeneca

Terminated

GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Type 2 Diabetes Mellitus

France, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
Munich Municipal Hospital
Novo Nordisk A/S

Unknown

Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Wellstat Therapeutics

Completed

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Wellstat Therapeutics

Completed

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Type 2 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

Type 2 Diabetes Mellitus

United States, Spain, United Kingdom
Sun Yat-sen University

Completed

Optimal Dietary Fat Pattern to Prevent Cardiovascular Disease Among Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Postgraduate Institute of Medical Education and...
Indian Council of Medical Research; International Clinical Epidemiology Network...

Unknown

Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes

Type 2 Diabetes Mellitus

India
Johns Hopkins Bloomberg School of Public Health
American Diabetes Association

Completed

Type 2 Diabetes Controlled Eating Experiment

Type 2 Diabetes Mellitus

United States
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Scripps Whittier Diabetes Institute
San Diego State University

Completed

Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings (MAC)

Type 2 Diabetes Mellitus (T2DM)

United States
Novartis Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus (T2DM)

United States
Merck Sharp & Dohme LLC

Completed

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

Type 2 Diabetes Mellitus (T2DM)
AstraZeneca
Bristol-Myers Squibb

Completed

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Type 2 Diabetes Mellitus (T2DM)

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients

Type 2 Diabetes Mellitus (T2DM)

Japan
PegBio Co., Ltd.

Recruiting

Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

China, Taiwan, Hong Kong
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin (ENHANCE-MEXT)

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Unknown

Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
ConjuChem

Terminated

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Type 2 Diabetes Mellitus (T2DM)

United States, Canada
Merck Sharp & Dohme LLC

Completed

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

Type 2 Diabetes Mellitus (T2DM)
Ligand Pharmaceuticals
Medpace, Inc.

Completed

A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation

Type 2 Diabetes Mellitus (T2DM)

United States
Merck Sharp & Dohme LLC
Pfizer

Completed

A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038)

Type 2 Diabetes Mellitus (T2DM)
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

United States
Wang Siqi
China-Japan Friendship Hospital

Not yet recruiting

Research on Changes in Intestinal Barrier Function and Gut Microbiome in Patients With Type 2 Diabetes After Duodenal Mucosal Resurfacing (DMR) (DMR-IBF-GM)

Type 2 Diabetes Mellitus
HighTide Biopharma Pty Ltd

Recruiting

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

China
Nanjing First Hospital, Nanjing Medical University

Recruiting

The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients

Type2 Diabetes Mellitus

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

China
Beijing Chao Yang Hospital

Not yet recruiting

Effectiveness of Shared Care Diabetes Management in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
HighTide Biopharma Pty Ltd
Shenzhen HighTide Biopharmaceutical Ltd.

Completed

A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise

Type 2 Diabetes Mellitus

China
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

Type 2 Diabetes Mellitus

China, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Japan, Czechia, Turkey, Korea, Republic... and more
Tehran University of Medical Sciences

Completed

Effectiveness of the Farsi Diabetes Self-management Education (FDSME) Program for People With Type 2 Diabetes (FDSME)

Type 2 Diabetes Mellitus
Eli Lilly and Company

Completed

A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India

Type 2 Diabetes Mellitus

India
Insulet Corporation

Completed

Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Baltimore VA Medical Center
University of Maryland, Baltimore

Active, not recruiting

Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes (EPC-DM)

Type 2 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Seoul National University Bundang Hospital
Astellas Pharma Korea, Inc.

Completed

Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin

Type 2 Diabetes Mellitus

Korea, Republic of
Sanofi

Completed

Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s) (Lixilan-O-AP)

Type 2 Diabetes Mellitus

China, Korea, Republic of, Malaysia, Taiwan
Sanofi

Completed

Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin (Lixilan-L-CN)

Type 2 Diabetes Mellitus

China
Beth Israel Deaconess Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo... and other collaborators

Completed

Memory Aid by Intranasal Insulin in Diabetes (MemAID) (MemAID)

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy (EDITION AP)

Type 2 Diabetes Mellitus

China, Taiwan, Korea, Republic of
Population Health Research Institute
Merck Sharp & Dohme LLC

Completed

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

Type 2 Diabetes Mellitus

Canada
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus

China, Mexico, Argentina
University Health Network, Toronto
Canadian Institutes of Health Research (CIHR); University of Toronto; MOUNT SINAI...

Terminated

Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
Theracos

Completed

Bexagliflozin Efficacy and Safety Trial (BEST)

Type 2 Diabetes Mellitus

United States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
Vinmec Research Institute of Stem Cell and Gene...

Completed

Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes (ASD2)

Type 2 Diabetes Mellitus

Vietnam
OPKO Health, Inc.

Completed

Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

United States

3

Subscribe